Global Enasidenib Drugs Market Research Report 2023

Report ID: 1897883 | Published Date: Sep 2024 | No. of Page: 69 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
1 Enasidenib Drugs Market Overview
    1.1 Product Overview and Scope of Enasidenib Drugs
    1.2 Enasidenib Drugs Segment by Type
        1.2.1 Global Enasidenib Drugs Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 50mg
        1.2.3 100mg
    1.3 Enasidenib Drugs Segment by Application
        1.3.1 Global Enasidenib Drugs Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital
        1.3.3 Pharmacy
    1.4 Global Enasidenib Drugs Market Size Estimates and Forecasts
        1.4.1 Global Enasidenib Drugs Revenue 2017-2028
        1.4.2 Global Enasidenib Drugs Sales 2017-2028
        1.4.3 Enasidenib Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Enasidenib Drugs Market Competition by Manufacturers
    2.1 Global Enasidenib Drugs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Enasidenib Drugs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Enasidenib Drugs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Enasidenib Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Enasidenib Drugs Market Competitive Situation and Trends
        2.5.1 Enasidenib Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Enasidenib Drugs Players Market Share by Revenue
        2.5.3 Global Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enasidenib Drugs Retrospective Market Scenario by Region
    3.1 Global Enasidenib Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Enasidenib Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Enasidenib Drugs Market Facts & Figures by Country
        3.3.1 North America Enasidenib Drugs Sales by Country
        3.3.2 North America Enasidenib Drugs Revenue by Country
        3.3.3 the United States
        3.3.4 Canada
    3.4 Europe Enasidenib Drugs Market Facts & Figures by Country
        3.4.1 Europe Enasidenib Drugs Sales by Country
        3.4.2 Europe Enasidenib Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 UK
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Enasidenib Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Enasidenib Drugs Sales by Region
        3.5.2 Asia Pacific Enasidenib Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Enasidenib Drugs Market Facts & Figures by Country
        3.6.1 Latin America Enasidenib Drugs Sales by Country
        3.6.2 Latin America Enasidenib Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Enasidenib Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Enasidenib Drugs Sales by Country
        3.7.2 Middle East and Africa Enasidenib Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Enasidenib Drugs Historic Market Analysis by Type
    4.1 Global Enasidenib Drugs Sales Market Share by Type (2017-2022)
    4.2 Global Enasidenib Drugs Revenue Market Share by Type (2017-2022)
    4.3 Global Enasidenib Drugs Price by Type (2017-2022)
5 Global Enasidenib Drugs Historic Market Analysis by Application
    5.1 Global Enasidenib Drugs Sales Market Share by Application (2017-2022)
    5.2 Global Enasidenib Drugs Revenue Market Share by Application (2017-2022)
    5.3 Global Enasidenib Drugs Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Celgene Corporation
        6.1.1 Celgene Corporation Corporation Information
        6.1.2 Celgene Corporation Description and Business Overview
        6.1.3 Celgene Corporation Enasidenib Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Celgene Corporation Enasidenib Drugs Product Portfolio
        6.1.5 Celgene Corporation Recent Developments/Updates
7 Enasidenib Drugs Manufacturing Cost Analysis
    7.1 Enasidenib Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Enasidenib Drugs
    7.4 Enasidenib Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Enasidenib Drugs Distributors List
    8.3 Enasidenib Drugs Customers
9 Enasidenib Drugs Market Dynamics
    9.1 Enasidenib Drugs Industry Trends
    9.2 Enasidenib Drugs Market Drivers
    9.3 Enasidenib Drugs Market Challenges
    9.4 Enasidenib Drugs Market Restraints
10 Global Market Forecast
    10.1 Enasidenib Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Enasidenib Drugs by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Enasidenib Drugs by Type (2023-2028)
    10.2 Enasidenib Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Enasidenib Drugs by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Enasidenib Drugs by Application (2023-2028)
    10.3 Enasidenib Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Enasidenib Drugs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Enasidenib Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Enasidenib Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Enasidenib Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Enasidenib Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Enasidenib Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Enasidenib Drugs Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Enasidenib Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Enasidenib Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Enasidenib Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Enasidenib Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Enasidenib Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Enasidenib Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Enasidenib Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enasidenib Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Enasidenib Drugs Sales by Region (2017-2022) & (K Units)
    Table 16. Global Enasidenib Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Enasidenib Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Enasidenib Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Enasidenib Drugs Sales by Country (2017-2022) & (K Units)
    Table 20. North America Enasidenib Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Enasidenib Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Enasidenib Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Enasidenib Drugs Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Enasidenib Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Enasidenib Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Enasidenib Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Enasidenib Drugs Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Enasidenib Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Enasidenib Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Enasidenib Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Enasidenib Drugs Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Enasidenib Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Enasidenib Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Enasidenib Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Enasidenib Drugs Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Enasidenib Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Enasidenib Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Enasidenib Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Enasidenib Drugs Sales by Type (2017-2022) & (K Units)
    Table 40. Global Enasidenib Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global Enasidenib Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Enasidenib Drugs Revenue Share by Type (2017-2022)
    Table 43. Global Enasidenib Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Enasidenib Drugs Sales (K Units) by Application (2017-2022)
    Table 45. Global Enasidenib Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global Enasidenib Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Enasidenib Drugs Revenue Share by Application (2017-2022)
    Table 48. Global Enasidenib Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 49. Celgene Corporation Corporation Information
    Table 50. Celgene Corporation Description and Business Overview
    Table 51. Celgene Corporation Enasidenib Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Celgene Corporation Enasidenib Drugs Product
    Table 53. Celgene Corporation Recent Developments/Updates
    Table 54. Production Base and Market Concentration Rate of Raw Material
    Table 55. Key Suppliers of Raw Materials
    Table 56. Enasidenib Drugs Distributors List
    Table 57. Enasidenib Drugs Customers List
    Table 58. Enasidenib Drugs Market Trends
    Table 59. Enasidenib Drugs Market Drivers
    Table 60. Enasidenib Drugs Market Challenges
    Table 61. Enasidenib Drugs Market Restraints
    Table 62. Global Enasidenib Drugs Sales Forecast by Type (2023-2028) & (K Units)
    Table 63. Global Enasidenib Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 64. Global Enasidenib Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 65. Global Enasidenib Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 66. Global Enasidenib Drugs Sales Forecast by Application (2023-2028) & (K Units)
    Table 67. Global Enasidenib Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 68. Global Enasidenib Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 69. Global Enasidenib Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 70. Global Enasidenib Drugs Sales Forecast by Region (2023-2028) & (K Units)
    Table 71. Global Enasidenib Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 72. Global Enasidenib Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 73. Global Enasidenib Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 74. Research Programs/Design for This Report
    Table 75. Key Data Information from Secondary Sources
    Table 76. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Enasidenib Drugs
    Figure 2. Global Enasidenib Drugs Market Share by Type in 2021 & 2028
    Figure 3. 50mg Product Picture
    Figure 4. 100mg Product Picture
    Figure 5. Global Enasidenib Drugs Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. Pharmacy
    Figure 8. Global Enasidenib Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Enasidenib Drugs Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Enasidenib Drugs Sales (2017-2028) & (K Units)
    Figure 11. Enasidenib Drugs Sales Share by Manufacturers in 2021
    Figure 12. Global Enasidenib Drugs Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Enasidenib Drugs Players: Market Share by Revenue in 2021
    Figure 14. Enasidenib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Enasidenib Drugs Sales Market Share by Region (2017-2022)
    Figure 16. Global Enasidenib Drugs Sales Market Share by Region in 2021
    Figure 17. Global Enasidenib Drugs Revenue Market Share by Region (2017-2022)
    Figure 18. Global Enasidenib Drugs Revenue Market Share by Region in 2021
    Figure 19. the United States Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. UK Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE Enasidenib Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of Enasidenib Drugs by Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of Enasidenib Drugs
    Figure 43. Manufacturing Process Analysis of Enasidenib Drugs
    Figure 44. Enasidenib Drugs Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Celgene Corporation
Frequently Asked Questions
Enasidenib Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Enasidenib Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Enasidenib Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Idhifa

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Mylotarg

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More